Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes
A clinical trial update describing the Super-Resolution Ultrasound Imaging of Erythrocytes (SURE) technique for imaging normal and malignant…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: A Study of the Safety and Efficacy of EBV Specific T-cell Lines [Phase 1, Phase 2]
A completed Phase 1/2 study evaluated the safety and efficacy of Epstein-Barr virus–specific T-cell lines in patients with Epstein-Barr viru…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies [Phase 1, Phase 2]
A Phase 1/2 clinical trial update announces CTS3497 for MTAP-deficient malignancies including solid tumors and lymphomas, currently recruiti…
-
CLINICAL_TRIALS withdrawal · 2025-05-13Clinical Trial Update: A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies [Phase 1]
A Phase I trial of donor-derived 19-28z CAR T cells following allogeneic transplant for CD19 malignancies has been withdrawn.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating chimeric antigen receptor natural killer (CAR-NK) cell therapy for high-risk lymphoma in patient…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma [Phase 2]
Phase 2 clinical trial evaluating Mecapegfilgrastim with chemotherapy for peripheral blood stem cell mobilization in adults with multiple my…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001) [Phase 2]
This clinical trial update notes that Balstilimab is being evaluated in a Phase 2 study (IMMONC0001) for relapsed/refractory lymphomas to as…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab [Phase 1]
This is a Phase 1/Ib study of NIZ985 alone and in combination with spartalizumab, sponsored by Novartis, which has been terminated.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma [Phase 1]
Phase 1 clinical trial evaluating a Carmustine, Etoposide, and Cyclophosphamide regimen with stem cell transplant for HIV-associated lymphom…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas [Phase 1]
This ClinicalTrials.gov update reports a Phase 1 dose-finding and safety study of CC-220, alone and in combination with an anti-CD20 monoclo…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Improving Patient Experience: BMBA [NA]
The BMBA clinical trial sponsored by Thomas Jefferson University has completed, but no specific results are provided in the update.
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
This clinical trial investigates the relationship between driver gene abnormalities and clinicopathological characteristics and prognosis in…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer [Phase 3]
Phase 3 clinical trial update on a web-based physical activity intervention to improve long-term health in children and adolescents with can…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic Factors [NA]
This trial update describes a longitudinal follow-up of lymphoma patients experiencing chemotherapy-induced peripheral neuropathy (CIPN) and…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Expression (MATCH - Subprotocol Z1H) [Phase 2]
Phase 2 MATCH subprotocol study evaluating copanlisib as a targeted treatment for cancers with PTEN expression. The trial is currently activ…
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO [NA]
A completed clinical trial comparing an active psycho-social intervention at diagnosis with usual care to improve psychosocial support in AY…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: AGMT Austrian Lymphoma Registry
An update on the AGMT Austrian Lymphoma Registry indicating the registry is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Progressive Muscle Relaxation Exercises on Sleep, Fatigue, Pain in Lymphoma Patients [NA]
A clinical trial evaluating progressive muscle relaxation exercises to improve sleep, fatigue, and pain in lymphoma patients, currently enro…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U) [Phase 2]
Phase 2 MATCH subprotocol U update on defactinib (VS-6063) for cancers with NF2 genetic changes, with results posted and the trial listed as…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial of VIP-152 in combination with Venetoclax and Prednisone in relapsed/refractory lymphoid malignancies has completed…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Assessing the Presence of CT-DNA in Lymphoma Associated HLH
A clinical trial is ongoing to assess circulating tumor DNA in patients with lymphoma-associated haemophagocytic lymphohistiocytosis (HLH); …
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Digital Peer Navigation for Adolescents and Young Adults With Cancer [NA]
ClinicalTrials.gov update on the Digital Peer Navigation for Adolescents and Young Adults With Cancer study, sponsored by University Health …
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies [Phase 1]
This is a Phase 1 clinical trial update on CD22-directed CAR T cells for children and young adults with B-cell malignancies, including B-cel…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas [Phase 1, Phase 2]
A Phase 1/2 trial of brentuximab vedotin combined with BeEAM high-dose chemotherapy for lymphoma has been suspended.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Whole Body MRI in Oncology
This clinical trial update describes a study evaluating whole-body MRI in oncology across multiple cancer types, currently recruiting.